Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
On April 6, 2020, months of nonstop work for Dr. Theel and her team culminated when Mayo Clinic’s first COVID-19 antibody test — the first commercial antibody test in the nation — was implemented.
In this episode, Paula Santrach, M.D., associate professor of laboratory medicine and pathology and consultant in Transfusion Medicine at Mayo Clinic, discusses cultivating quality in the clinical practice.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., discuss the current rate of COVID-19 vaccination in the U.S. and address common questions about the vaccines.
Mayo Clinic Laboratories will be migrating the MayoACCESS application to the authentication service used across Mayo Clinic.
A case study published on Practice Greenhealth detailed how the change in freezers will reduce energy use by more than 60% and save more than $6 million over 10 years.
This week’s research roundup features a study on how a noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
Top highlights include: Importance of preventive health care during the COVID-19 pandemic, understanding vaccine side effects, and what recent studies show about pregnancy and the COVID-19 vaccine.
Mayo Clinic's use of enhanced radio-frequency identification technology to track specimens from the clinical setting to the lab reduces the risk of errors and protects valuable — sometime irreplaceable — patient samples.
Dr. Binnicker's experience developing Mayo Clinic's first diagnostic COVID-19 test was recently featured in Mayo Clinic Alumni magazine.
Mayo Clinic and Thermo Fisher have joined forces to bring innovative solutions to patients.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update. In this episode, Dr. Morice and Bobbi Pritt, M.D., take a look at issues contributing to COVID-19 vaccine hesitancy. They address common myths surrounding the vaccines and discuss vaccine safety.
This week’s research roundup features a study on the impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening.